Literature DB >> 11759233

[Clinical quality management in rheumatoid arthritis].

T Langenegger1, J Fransen, A Forster, M Seitz, B A Michel.   

Abstract

Clinical quality management in rheumatoid arthritis (RA) aims at reducing inflammatory activity and pain in the short term and damage and disability in the long term. In the "Swiss Clinical Quality Management in rheumatoid arthritis" (SCQM) project, which started in 1997, a measurement-improvement system with feedback reports allows the rheumatologists to follow their RA patients with the aim of improving the quality of outcome. Inflammatory activity is measured with the Disease Activity Score (DAS28) and the Rheumatoid Arthritis Disease Activity Index questionnaire (RADAI), damage with an X-ray score and disability with the Stanford Health Assessment Questionnaire (HAQ). The feedback is used by the individual rheumatologist to optimize the therapy of his/her RA patients. Beside the aim of improving the quality of treatment, the SCQM projects wants to build a Swiss cohort of RA patients, to improve the collaboration of rheumatologists in the clinic and in practice and to establish standards of treatment in RA. In this paper we describe the SCQM project in detail, we show two cases illustrating the usefulness of the SCQM in the management of individual RA patients, and we present the cross sectional analysis of the first 1223 RA patients included in the project.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11759233     DOI: 10.1007/s003930170033

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  5 in total

Review 1.  [Tapering and termination of immunosuppressive treatment in spondyloarthritides (including psoriatic arthritis)].

Authors:  G Scholz; B Möller
Journal:  Z Rheumatol       Date:  2017-02       Impact factor: 1.372

2.  Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis.

Authors:  A Finckh; J F Simard; C Gabay; P-A Guerne
Journal:  Ann Rheum Dis       Date:  2005-12-08       Impact factor: 19.103

3.  Cigarette smoking and radiographic progression in rheumatoid arthritis.

Authors:  A Finckh; S Dehler; K H Costenbader; C Gabay
Journal:  Ann Rheum Dis       Date:  2007-01-19       Impact factor: 19.103

4.  Combining individual patient data from randomized and non-randomized studies to predict real-world effectiveness of interventions.

Authors:  Michael Seo; Thomas Pa Debray; Yann Ruffieux; Sandro Gsteiger; Sylwia Bujkiewicz; Axel Finckh; Matthias Egger; Orestis Efthimiou
Journal:  Stat Methods Med Res       Date:  2022-04-26       Impact factor: 2.494

5.  Collaborative Challenges of Multi-Cohort Projects in Pharmacogenetics-Why Time Is Essential for Meaningful Collaborations.

Authors:  Filippo Franchini; Katharina Kusejko; Catia Marzolini; Christoph Tellenbach; Simona Rossi; Susanne Stampf; Michael Koller; Jivko Stoyanov; Burkhard Möller; Alexander Benedikt Leichtle
Journal:  JMIR Form Res       Date:  2022-09-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.